Literature DB >> 3283656

Detection of activated ras oncogenes in human thyroid carcinomas.

H G Suárez1, J A Du Villard, B Caillou, M Schlumberger, M Tubiana, C Parmentier, R Monier.   

Abstract

Focus formation following DNA transfection of mouse 3T3-Vill cells was used to search for the presence of activated oncogenes in human thyroid tumors. Oncogenes belonging to the ras family were detected in four out of six thyroid carcinomas (Ki-ras in one anaplastic tumor and one follicular moderately differentiated tumor and Ha-ras and N-ras in two papillary tumors). Normal thyroid tissue samples obtained from two patients, one with an anaplastic tumor and one with a benign adenoma, and samples from 4 benign adenomas and from one toxic goiter of a patient with Graves' disease gave negative results. In one case, restriction enzyme analysis demonstrated the presence of a mutation in codon 12 of the activated Ha-ras oncogene. Our data show that all three ras proto-oncogenes can become activated in malignant thyroid tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3283656

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

Review 1.  Molecular pathology of thyroid cancer: diagnostic and clinical implications.

Authors:  James A Fagin; Nicholas Mitsiades
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-12       Impact factor: 4.690

2.  Oncogenicity of human N-ras oncogene and proto-oncogene introduced into retroviral vectors.

Authors:  M Souyri; I Vigon; M Charon; P Tambourin
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

Review 3.  Coding Molecular Determinants of Thyroid Cancer Development and Progression.

Authors:  Veronica Valvo; Carmelo Nucera
Journal:  Endocrinol Metab Clin North Am       Date:  2018-12-23       Impact factor: 4.741

Review 4.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

5.  Gilbert W. Beebe Symposium on 30 Years after the Chernobyl Accident: Current and Future Studies on Radiation Health Effects.

Authors:  Jonathan M Samet; Amy Berrington de González; Lawrence T Dauer; Maureen Hatch; Ourania Kosti; Fred A Mettler; Merriline M Satyamitra
Journal:  Radiat Res       Date:  2017-11-14       Impact factor: 2.841

6.  Role of ras and gsp oncogenes in human epithelial thyroid tumorigenesis.

Authors:  J A Du Villard; M Schlumberger; R Wicker; B Caillou; P Rochefort; J Feunteun; R Monier; C Parmentier; H G Suarez
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

Review 7.  Thyroid cancer: a review of treatment and follow-up.

Authors:  L Vini; C Harmer; V R McCready
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

8.  Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study).

Authors:  Mosin S Khan; Arshad A Pandith; Mahboob Ul Hussain; Mohammad Iqbal; Nighat P Khan; Khurshid A Wani; Shariq R Masoodi; Syed Mudassar
Journal:  Tumour Biol       Date:  2012-11-13

9.  Ki-ras mutational analysis in rat follicular-cell proliferative lesions of the thyroid gland induced by radioactive iodine and potassium perchlorate.

Authors:  J M Fernández-Santos; M De-Miguel; R González-Cámpora; M Salguero-Villadiego; J J Cabrera; H Galera-Davidson
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

Review 10.  RAS mutations in thyroid cancer.

Authors:  Gina M Howell; Steven P Hodak; Linwah Yip
Journal:  Oncologist       Date:  2013-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.